Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secretoglobin family 3A member 1 (SCGB3A1) is a small, secreted cytokine-like protein encoded by the SCGB3A1 gene in humans[2][4][5]. It is predicted to act as a cytokine, localized in the extracellular space, and is notably involved in the inhibition of cell growth and the positive regulation of myoblast fusion[1][4][5]. Diseases associated with SCGB3A1 include atrophy of the prostate and adenoid hypertrophy. The protein is also sometimes referred to as "High in normal-1" (HIN-1), indicating a potential role in tissue homeostasis and response to pathological states[1][5]. There is no direct evidence for specific drug interactions, biomarker roles, or safety concerns in the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secretoglobin family 3A member 1 (SCGB3A1).